Indonesia Takes Steps to Reduce Dependence on Imported Pharmaceutical Raw Materials

Rama Sukarta
August 7, 2024 | 8:16 pm
SHARE
Acting Head of BPOM Rizka Andalusia (center), along with Dr. Isabella Kurnia Liem from the Indonesian Anatomists Association (second left), Rita Endang, Deputy for Drug, Narcotics, Psychotropics, Precursors, and Addictive Substances Supervision (third right), Prof. Raymond R. Tjandrawinata, Business Development and Scientific Affairs Director at Dexa Group (second right), and Noffendri Roestam, Chairman of PP IAI (right), participated as speakers in a Focus Group Discussion on "Health Innovation in Promoting the Pharmaceutical Industry," with the editorial team of B-Universe at the B-Universe office in Tangerang, Banten, on Wednesday, August 7, 2024. (Photo by Berita Satu/Joanito De Saojoao)
Acting Head of BPOM Rizka Andalusia (center), along with Dr. Isabella Kurnia Liem from the Indonesian Anatomists Association (second left), Rita Endang, Deputy for Drug, Narcotics, Psychotropics, Precursors, and Addictive Substances Supervision (third right), Prof. Raymond R. Tjandrawinata, Business Development and Scientific Affairs Director at Dexa Group (second right), and Noffendri Roestam, Chairman of PP IAI (right), participated as speakers in a Focus Group Discussion on "Health Innovation in Promoting the Pharmaceutical Industry," with the editorial team of B-Universe at the B-Universe office in Tangerang, Banten, on Wednesday, August 7, 2024. (Photo by Berita Satu/Joanito De Saojoao)

Tangerang. Indonesia is working to reduce its reliance on imported pharmaceutical raw materials (BBO), which currently make up 90 percent of the country’s needs, primarily from China and India.

Elfiano Rizaldi, Executive Director of the Indonesian Pharmaceutical Companies Association, praised the government’s efforts to regulate BBO imports but stressed the importance of strengthening research and development (R&D).

“Law No. 17 of 2023 on Health and Government Regulation No. 28 of 2024 aim to reduce dependency on imported chemical drug raw materials. However, increasing R&D funding from both the government and industry is crucial for supporting these efforts,” Elfiano said during a Focus Group Discussion at B-Universe Office in Tangerang Regency, Banten, on Wednesday.

Elfiano also highlighted the need for Indonesia to develop its basic chemical industry, calling for the establishment of chemical plants capable of producing pharmaceutical chemicals. He expressed confidence that Indonesia has the necessary infrastructure and human resources.

Advertisement

“The infrastructure and workforce are ready. The challenge now is to build a comprehensive ecosystem involving around 12 ministries and agencies,” he added.

Acting Head of the National Agency of Drug and Food Control (BPOM), Rizka Andalusia, revealed that BPOM is collaborating with industry players to develop the domestic BBO industry, aiming to cut imports by Rp 1.5 trillion through domestic production of 22 BBOs.

“Achieving this reduction within this year could significantly lower import values next year,” Rizka said.

BPOM is also preparing a Regulatory Impact Assessment with the Industry Ministry to guide import regulations for BBO, potentially benefiting the national private sector. Rizka noted that domestic manufacturers like Kimia Farma and Brightgene are already producing BBOs, which could further reduce import values.

Meanwhile, Noffendri Roestam, Chairman of the Indonesian Pharmacists Association (PP IAI), expressed concerns about the low drug prices set under the National Health Insurance (JKN) scheme, which he believes hinders R&D funding in the pharmaceutical industry.

“We hope the government will revisit and adjust JKN drug prices to provide more financial flexibility for R&D, especially for raw materials,” Noffendri said.

He also agreed with Prof. Raymond R. Tjandrawinata of Dexa Group that improved drug quality contributes to increased life expectancy in Indonesia.

“Higher life expectancy is influenced by better health and quality medications. The quality of drugs provided in Indonesia plays a crucial role in maintaining public health,” Noffendri concluded.

Tags: Keywords:
SHARE

The Latest


News 4 hours ago

Justice Department Uncovers Iranian Plot to Assassinate Trump, Arrests Made

The Justice Department on Friday revealed criminal charges in an Iranian murder-for-hire plot targeting Donald Trump
Business 4 hours ago

Indonesia Extends Tax Holiday to 2025: A Guide for Investors

The government has officially extended the tax holiday facility until December 31, 2025
Lifestyle 5 hours ago

Visa on Arrival Extensions in Indonesia Now Require Immigration Verification: What You Need to Know

Foreign nationals seeking an extension for their Visa on Arrival (VoA) will now need to undergo verification by the immigration office
Lifestyle 5 hours ago

Dua Lipa "Heartbroken" as Jakarta Concert Is Cancelled at the Last Minute

Dua Lipa’s much-anticipated concert in Jakarta, part of her Radical Optimism tour, has been canceled due to safety and logistical issues.
News 8 hours ago

West Jakarta Police Arrest Eight in Online Gambling Operation Tied to Cambodian Network

West Jakarta Police raided a home in West Jakarta, dismantling an operation allegedly tied to a Cambodian online gambling network.
COPYRIGHT © 2024 JAKARTA GLOBE. ALL RIGHTS RESERVED